Mortality risk prediction in scleroderma-related interstitial lung disease: the SADL model
J Morisset, E Vittinghoff, BM Elicker, X Hu, S Le, JH Ryu… - Chest, 2017 - Elsevier
Background Interstitial lung disease (ILD) is an important cause of morbidity and mortality in
patients with scleroderma (Scl). Risk prediction and prognostication in patients with Scl-ILD
are challenging because of heterogeneity in the disease course. Methods We aimed to
develop a clinical mortality risk prediction model for Scl-ILD. Patients with Scl-ILD were
identified from two ongoing longitudinal cohorts: 135 patients at the University of California,
San Francisco (derivation cohort) and 90 patients at the Mayo Clinic (validation cohort) …
patients with scleroderma (Scl). Risk prediction and prognostication in patients with Scl-ILD
are challenging because of heterogeneity in the disease course. Methods We aimed to
develop a clinical mortality risk prediction model for Scl-ILD. Patients with Scl-ILD were
identified from two ongoing longitudinal cohorts: 135 patients at the University of California,
San Francisco (derivation cohort) and 90 patients at the Mayo Clinic (validation cohort) …
